project id: TCGA-TGCT; case submitter id: TCGA-2G-AAG6; source center: 23; state: released; a260 a280 ratio: 1.9; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.48; rna integrity number: 7.9; age at index: 24; days to birth: -9071; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1984; age at diagnosis: 9071; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IS; ajcc clinical t: T1; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IS; ajcc pathologic t: T1; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 2231.0; icd 10 code: C62.90; last known disease status: not reported; morphology: 9080/0; primary diagnosis: Teratoma, benign; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Testis, NOS; synchronous malignancy: No; tissue or organ of origin: Testis, NOS; tumor grade: Not Reported; year of diagnosis: 2008; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 1964; days to sample procurement: 0; initial weight: 210.0; portion submitter id: TCGA-2G-AAG6-01A-11; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 1.0; percent necrosis: 0.0; percent neutrophil infiltration: 1.0; percent normal cells: 0.0; percent stromal cells: 30.0; percent tumor cells: 70.0; percent tumor nuclei: 70.0;